332 related articles for article (PubMed ID: 22381427)
1. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis.
Zhang L; Lu Y; Jiang H; Zhang L; Sun A; Zou Y; Ge J
J Am Coll Cardiol; 2012 Mar; 59(10):913-22. PubMed ID: 22381427
[TBL] [Abstract][Full Text] [Related]
2. Is treatment with trimetazidine beneficial in patients with chronic heart failure?
Zhou X; Chen J
PLoS One; 2014; 9(5):e94660. PubMed ID: 24797235
[TBL] [Abstract][Full Text] [Related]
3. Effects of fish oil supplementation on cardiac function in chronic heart failure: a meta-analysis of randomised controlled trials.
Xin W; Wei W; Li X
Heart; 2012 Nov; 98(22):1620-5. PubMed ID: 22760864
[TBL] [Abstract][Full Text] [Related]
4. Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis.
Hu LJ; Chen YQ; Deng SB; Du JL; She Q
Br J Clin Pharmacol; 2013 May; 75(5):1202-12. PubMed ID: 23088367
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy.
Di Napoli P; Di Giovanni P; Gaeta MA; D'Apolito G; Barsotti A
Am Heart J; 2007 Sep; 154(3):602.e1-5. PubMed ID: 17719313
[TBL] [Abstract][Full Text] [Related]
6. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
Fragasso G; Palloshi A; Puccetti P; Silipigni C; Rossodivita A; Pala M; Calori G; Alfieri O; Margonato A
J Am Coll Cardiol; 2006 Sep; 48(5):992-8. PubMed ID: 16949492
[TBL] [Abstract][Full Text] [Related]
8. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
Fragasso G; Perseghin G; De Cobelli F; Esposito A; Palloshi A; Lattuada G; Scifo P; Calori G; Del Maschio A; Margonato A
Eur Heart J; 2006 Apr; 27(8):942-8. PubMed ID: 16510466
[TBL] [Abstract][Full Text] [Related]
9. Effects of statin treatment on cardiac function in patients with chronic heart failure: a meta-analysis of randomized controlled trials.
Zhang L; Zhang S; Jiang H; Sun A; Zou Y; Ge J
Clin Cardiol; 2011 Feb; 34(2):117-23. PubMed ID: 21298656
[TBL] [Abstract][Full Text] [Related]
10. Trimetazidine: a meta-analysis of randomised controlled trials in heart failure.
Gao D; Ning N; Niu X; Hao G; Meng Z
Heart; 2011 Feb; 97(4):278-86. PubMed ID: 21134903
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of randomized controlled trials comparing isolated left ventricular and biventricular pacing in patients with chronic heart failure.
Liang Y; Pan W; Su Y; Ge J
Am J Cardiol; 2011 Oct; 108(8):1160-5. PubMed ID: 21813108
[TBL] [Abstract][Full Text] [Related]
12. Trimetazidine improves exercise tolerance in patients with ischemic heart disease : A meta-analysis.
Zhao Y; Peng L; Luo Y; Li S; Zheng Z; Dong R; Zhu J; Liu J
Herz; 2016 Sep; 41(6):514-22. PubMed ID: 26668006
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of statin therapy in chronic systolic cardiac insufficiency: a meta-analysis.
Zhang S; Zhang L; Sun A; Jiang H; Qian J; Ge J
Eur J Intern Med; 2011 Oct; 22(5):478-84. PubMed ID: 21925056
[TBL] [Abstract][Full Text] [Related]
14. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
Belardinelli R; Cianci G; Gigli M; Mazzanti M; Lacalaprice F
J Cardiovasc Pharmacol; 2008 Jun; 51(6):611-5. PubMed ID: 18574390
[TBL] [Abstract][Full Text] [Related]
15. Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure.
Fragasso G; Salerno A; Lattuada G; Cuko A; Calori G; Scollo A; Ragogna F; Arioli F; Bassanelli G; Spoladore R; Luzi L; Margonato A; Perseghin G
Heart; 2011 Sep; 97(18):1495-500. PubMed ID: 21700755
[TBL] [Abstract][Full Text] [Related]
16. [Effects of trimetazidine on serum oxygen free radicals in congestive heart failure].
Ma QL; Xie Y; Zhang SD
Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):527-9. PubMed ID: 12658930
[TBL] [Abstract][Full Text] [Related]
17. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.
Fragasso G; Piatti Md PM; Monti L; Palloshi A; Setola E; Puccetti P; Calori G; Lopaschuk GD; Margonato A
Am Heart J; 2003 Nov; 146(5):E18. PubMed ID: 14597947
[TBL] [Abstract][Full Text] [Related]
18. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK
Klin Med (Mosk); 2004; 82(11):15-20. PubMed ID: 15656392
[TBL] [Abstract][Full Text] [Related]
19. Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an international multicentre retrospective cohort study.
Fragasso G; Rosano G; Baek SH; Sisakian H; Di Napoli P; Alberti L; Calori G; Kang SM; Sahakyan L; Sanosyan A; Vitale C; Marazzi G; Margonato A; Belardinelli R
Int J Cardiol; 2013 Mar; 163(3):320-325. PubMed ID: 23073279
[TBL] [Abstract][Full Text] [Related]
20. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
Di Napoli P; Di Giovanni P; Gaeta MA; Taccardi AA; Barsotti A
J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
